Key drivers for each region include: for North America, investments in genomics and proteomics research, policies supporting personalized medicine, and a mature ecosystem; for Europe, demographics driving demand for diagnostic solutions, infrastructure development in research institutions, and regulatory frameworks supporting innovation; for Asia Pacific, growing demand for point-of-care diagnostics, partnerships between research institutions and industry players, and government initiatives to promote biotechnology; for Latin America, increasing access to healthcare services, public-private partnerships in research and development, and growing awareness of genetic diseases; and for Middle East & Africa, growing investment in healthcare infrastructure, rising demand for diagnostic services, and expanding research collaborations.